Dermatology (DER)

Dermatology (DER)

DER Overview

From common diseases to complicated ones, faculty members in USU'S Department of Dermatology teach medical students, residents and staff physicians important lessons about skin. This knowledge is harnessed inside the military's best hospitals to treat a host of skin-related problems, from psoriasis and rosacea to immune disorders and cancer.

Besides educating the next generation of uniformed physicians, faculty members at USU also push research boundaries through original investigations that happen on campus and through collaborations with leading dermatologists in the world's best laboratories. This cutting-edge work continues improving all levels of skin care, from earlier diagnoses for troubling, sometimes life-threatening diseases to better, more comprehensive treatments for healthier uniformed forces.

Explore these web pages to learn more about dermatology education and research at USU.

DER Contact Info

Uniformed Services University of the Health Sciences
4301 Jones Bridge Road
Bethesda, Maryland 20814

Administrative Assistant
Leonor McKay
Phone: (301) 295-9802

DER homepage img

Dermatology News

USU dermatologist advances clinical care

COL Jon Meyerle was recognized in 2017 as a Master Clinician at Walter Reed National Military Medical Center.  The “Master Clinician” is typified by high clinical volume, proven excellent outcomes, superior patient satisfaction, significant contributions to the profession, and outstanding professionalism. COL Meyerle was featured on Health.mil for his work with amputees and total body skin digital imaging.  https://www.health.mil/News/Articles/2018/02/06/Caring-for-skin-goes-deeper-than-applying-lotion .
 

USU scientists link biomarker to tumors

The Darling laboratory studies cell signaling pathways to uncover new approaches for regenerating skin and treating cancers. They found that galectin-3 may be a useful biomarker to assess tumor severity in diseases with activation of the mTOR signaling pathway, and to detect cancers with mutations in genes that regulate mTOR activity. These results were published in a 2017 article in eLife and featured in a USUHS new release.